arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

SOPHiA GENETICS SA

SOPH Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$8.20
▲ +1.4% Today
as of Sep 4, 16:54 ET
Last 30 days +45.24% Jul 28 → Sep 04
$5.28 $6.26 $7.24 $8.21 $9.19 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$8.24
High
$8.30
Low
$8.06
Volume
$147,033
Avg Vol
$205,334
Mkt Cap
$649M
P/E (TTM)
—
Beta
—
52w High
$8.98
52w Low
$3.10
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 13 items

Sep 4 · 13:08 Simply Wall St.
SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance Raise
Aug 11 · 16:46 Motley Fool
SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript
Aug 5 · 09:45 Medical Device Network
SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics
▸ Show all 13 press releases & news Free account →

Overview

52-week range
$3.10
$8.98
87% of range
Avg surprise (last 1)
-23.8%
Avg reaction (last 2)
-4.3%
0% positive
Latest IV / EM
125%
EM ±19.5% · $8 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.27$-0.12$0.03$0.18$0.33 Actual $-0.26Est $-0.21Actual $0.33Actual $-0.27 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $-0.27 — — -3.9% -4.2% earnings
Tue Aug 5, 2025Jun/2025 $0.33 — — — — earnings
Tue May 6, 2025Mar/2025 $-0.26 $-0.21 -23.8% — -4.5% earnings

Implied volatility — last 90 days

62%216%369%523%677% Jun 07 — IV 166% · EM ±23.0%Jun 08 — IV 108% · EM ±14.2%Jun 09 — IV 148% · EM ±18.5%Jun 16 — IV 242% · EM ±14.3%Jun 17 — IV 110% · EM ±4.6%Jun 19 — IV 62% · EM ±13.7%Jun 23 — IV 93% · EM ±19.1%Jun 25 — IV 111% · EM ±21.7%Jun 26 — IV 158% · EM ±30.2%Jun 29 — IV 198% · EM ±35.1%Jun 30 — IV 232% · EM ±40.0%Jul 01 — IV 178% · EM ±29.7%Jul 02 — IV 110% · EM ±17.8%Jul 03 — IV 114% · EM ±17.8%Jul 07 — IV 118% · EM ±15.6%Jul 08 — IV 196% · EM ±24.5%Jul 13 — IV 324% · EM ±27.1%Jul 14 — IV 414% · EM ±29.9%Jul 15 — IV 470% · EM ±27.7%Jul 16 — IV 678% · EM ±28.3%Jul 20 — IV 122% · EM ±28.9%Jul 21 — IV 114% · EM ±26.5%Jul 22 — IV 150% · EM ±34.4%Jul 23 — IV 257% · EM ±57.9%Jul 24 — IV 170% · EM ±37.6%Jul 27 — IV 153% · EM ±31.9%Jul 28 — IV 123% · EM ±25.1%Jul 29 — IV 141% · EM ±28.2%Jul 30 — IV 201% · EM ±39.3%Aug 03 — IV 149% · EM ±26.4%Aug 04 — IV 134% · EM ±23.1%Aug 05 — IV 257% · EM ±42.9%Aug 06 — IV 225% · EM ±36.4%Aug 07 — IV 104% · EM ±16.3%Aug 10 — IV 89% · EM ±12.4%Aug 11 — IV 90% · EM ±11.9%Aug 13 — IV 89% · EM ±10.5%Aug 19 — IV 256% · EM ±15.1%Aug 20 — IV 359% · EM ±15.0%Aug 24 — IV 113% · EM ±23.7%Aug 25 — IV 113% · EM ±23.1%Aug 26 — IV 100% · EM ±19.9%Aug 27 — IV 174% · EM ±34.1%Aug 28 — IV 111% · EM ±21.3%Aug 31 — IV 138% · EM ±24.4%Sep 01 — IV 124% · EM ±21.4%Sep 02 — IV 112% · EM ±18.7%Sep 03 — IV 119% · EM ±19.3%Sep 04 — IV 125% · EM ±19.5%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in